IPO Timeline
Broker Results (T-2)
2023-11-15
Some brokers release in afternoon
Grey Market (T-1)
2023-11-16
Afternoon
HKEX Allotment (T-1)
2023-11-16
Evening
Registrar Allotment (T-1)
2023-11-16
Evening
Listing Day (T)
2023-11-17
First day of trading
Company Overview
| Stock Name | 药明合联 |
|---|---|
| Stock Code | 02268 |
| Company Full Name | 药明合联 |
| Industry | 醫療保健 |
| Principal Activities | 公司是專注于全球ADC及更廣泛生物偶聯藥物市場的領先CRDMO，亦是一家致力于提供全面綜合服務的公司。 |
| Listing Date | 2023-11-17 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國江蘇省無錫市新吳區新輝環路11號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://wuxixdc.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 20.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 63.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,102,800,400 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 10,300 |
| 2 lots | 1,000 | HK$ 20,600 |
| 3 lots | 1,500 | HK$ 30,900 |
| 4 lots | 2,000 | HK$ 41,200 |
| 5 lots | 2,500 | HK$ 51,500 |
| 6 lots | 3,000 | HK$ 61,800 |
| 7 lots | 3,500 | HK$ 72,100 |
| 8 lots | 4,000 | HK$ 82,400 |
| 9 lots | 4,500 | HK$ 92,700 |
| 10 lots | 5,000 | HK$ 103,000 |
| 12 lots | 6,000 | HK$ 123,600 |
| 14 lots | 7,000 | HK$ 144,200 |
| 16 lots | 8,000 | HK$ 164,800 |
| 18 lots | 9,000 | HK$ 185,400 |
| 20 lots | 10,000 | HK$ 206,000 |
| 30 lots | 15,000 | HK$ 309,000 |
| 40 lots | 20,000 | HK$ 412,000 |
| 50 lots | 25,000 | HK$ 515,000 |
| 60 lots | 30,000 | HK$ 618,000 |
| 70 lots | 35,000 | HK$ 721,000 |
| 80 lots | 40,000 | HK$ 824,000 |
| 90 lots | 45,000 | HK$ 927,000 |
| 100 lots | 50,000 | HK$ 1,030,000 |
| 120 lots | 60,000 | HK$ 1,236,000 |
| 140 lots | 70,000 | HK$ 1,442,000 |
| 160 lots | 80,000 | HK$ 1,648,000 |
| 180 lots | 90,000 | HK$ 1,854,000 |
| 200 lots | 100,000 | HK$ 2,060,000 |
| 250 lots | 125,000 | HK$ 2,575,000 |
| 300 lots | 150,000 | HK$ 3,090,000 |
| 350 lots | 175,000 | HK$ 3,605,000 |
| 400 lots | 200,000 | HK$ 4,120,000 |
| 450 lots | 225,000 | HK$ 4,635,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 500 lots | 250,000 | HK$ 5,150,000 |
| 1,000 lots | 500,000 | HK$ 10,300,000 |
| 1,500 lots | 750,000 | HK$ 15,450,000 |
| 2,000 lots | 1,000,000 | HK$ 20,600,000 |
| 4,000 lots | 2,000,000 | HK$ 41,200,000 |
| 6,000 lots | 3,000,000 | HK$ 61,800,000 |
| 8,000 lots | 4,000,000 | HK$ 82,400,000 |
| 10,000 lots | 5,000,000 | HK$ 103,000,000 |
| 12,000 lots | 6,000,000 | HK$ 123,600,000 |
| 14,000 lots | 7,000,000 | HK$ 144,200,000 |
| 17,845 lots | 8,922,500 | HK$ 183,803,500 |
| 187,679 lots | 93,839,657 | HK$ 1,933,096,934 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 2.52 |
|---|---|
| First Day Open | HK$ 2.3 |
| First Day Change | -2.30% |
| First Day Volume | 66988000.0 |
| First Day Turnover | 159746000.0 |
Use of Proceeds
| Use of Proceeds | 1、約67%或2,333.8百萬港元將用于(i)在新加坡興建我們的設施及(ii)擴大我們在中國的服務實力及能力，以進一步擴大服務實力及能力； 2、約23%或801.2百萬港元將用于有選擇地尋求戰略聯盟、投資及收購機會，主要旨在擴大技術平臺及服務類型和能力； 3、約10%或348.3百萬港元用作營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (3)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
J.P. Morgan Securities (Far East) Limited CE AAB026
Overall Coordinators (6)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
花旗环球金融亚洲有限公司 CE AAA137
华泰金融控股（香港）有限公司 CE AOK809
Joint Bookrunners (6)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
花旗环球金融亚洲有限公司 CE AAA137
华泰金融控股（香港）有限公司 CE AOK809
Joint Lead Managers (6)
摩根士丹利亚洲有限公司 CE AAD291
高盛（亚洲）有限责任公司 CE ACC536
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
花旗环球金融亚洲有限公司 CE AAA137
华泰金融控股（香港）有限公司 CE AOK809
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Al-Rayyan Holding LLC | 351,981,900 HKD | — | 9.58% | — | 6 months | 2024-05-17 |
| 2 | General Atlantic Singapore SPV 64 Pte. Ltd. | 391,091,000 HKD | — | 10.64% | — | 6 months | 2024-05-17 |
| 3 | HongShan Funds | 234,654,600 HKD | — | 6.38% | — | 6 months | 2024-05-17 |
| 4 | Invesco Advisers, Inc. | 782,182,000 HKD | — | 21.28% | — | 6 months | 2024-05-17 |
| 5 | Lake Bleu Prime Healthcare Master Fund Limited | 78,218,200 HKD | — | 2.13% | — | 6 months | 2024-05-17 |
| 6 | Novo Holdings A/S | 195,545,500 HKD | — | 5.32% | — | 6 months | 2024-05-17 |
| 7 | UBS Asset Management (Singapore) Ltd. | 312,872,800 HKD | — | 8.51% | — | 6 months | 2024-05-17 |
Directors & Management
| Chairman | 陳智勝 |
|---|---|
| Company Secretary | 席曉捷 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 藥明生物技術有限公司(50.91%);合全藥業香港投資有限公司(33.94%) |
|---|
Subscription Tiers
IPO Timeline
